{
	"kj8tvw9mText": "Pa<span class=\"_ _0\"></span>t<span class=\"_ _1\"></span>ien<span class=\"_ _0\"></span>t<span class=\"_ _1\"></span>s wit<span class=\"_ _1\"></span>h MDD treated with<span class=\"_ _1\"></span> Brintel<span class=\"_ _0\"></span>lix® <br><span class=\"ls16 ws2b\">demons<span class=\"_ _1\"></span>t<span class=\"_ _1\"></span>rated improv<span class=\"_ _0\"></span>ement<span class=\"_ _1\"></span>s in<span class=\"_ _1\"></span> measures o<span class=\"_ _1\"></span>f anhedonia<span class=\"_ _0\"></span><span class=\"fs2 ls17 v1\">†1</span></span>",
	"kj8tvw9nText": "Change in SHAPS scores ",
	"kj8tvw9oText": "from baseline",
	"kj8tvw9pText": "Change in MADRS anhedonia",
	"kj8tvw9qText": "factor scores fr<span class=\"_ _0\"></span>om baseline",
	"kj8tvw9rText": "†<span class=\"fsa wsa v6\">As measured by improvements in SHAPS scores and MADRS anhedonia factor scor<span class=\"_ _0\"></span>es. SHAPS (Snaith-Hamilton Pleasure Scale) scor<span class=\"_ _0\"></span>e was a pre-planned secondary <br>outcome measure. MADRS (Montgomery-Åsber<span class=\"_ _0\"></span>g Depression Ra<span class=\"_ _0\"></span>ting Scale) anhedonia factor consisted of MADRS items: 1 (apparent sadness), 2 (reported sadness),<span class=\"_ _0\"></span> <br>6 (concentration. dif<span class=\"_ _0\"></span>ficulties), 7 (lassitude), 8 (inability to feel).<span class=\"_ _0\"></span> SDS, Sheehan Disability Scale; WHO-5,<span class=\"_ _0\"></span> 5-Item World Health Or<span class=\"_ _0\"></span>ganization Well-Being Index.</span>",
	"kj8tvw9sText": "SHAPS score",
	"kj8tvw9tText": "MADRS anhedonia factor score",
	"kj8tvw9uText": " “<span class=\"_ _2\"></span>Anhedonia ",
	"kj8tvw9vText": "is a common ",
	"kj8tvw9wText": "symptom of ",
	"kj8tvw9xText": "MDD reported ",
	"kj8tvw9yText": "in ~75% of ",
	"kj8tvw9zText": "patients” ",
	"kj8tvwa0Text": "P<span class=\"_ _2\"></span>ost-hoc analyses of<span class=\"_ _1\"></span> an open-label study showed that impr<span class=\"_ _0\"></span>ovements in anhedonia correlated with <br>improvements in gener<span class=\"_ _0\"></span>al function (as measured by SDS) and quality of life (as measured by WHO-5) <br>in pa<span class=\"_ _0\"></span>tients treated with Brintellix®<span class=\"fsf v3\">1</span>",
	"kj8tvwa1Text": "Brintellix® 10-20 mg",
	"kj8tvwa2Text": "Baseline (n=95)<span class=\"_ _24\"> </span>Baseline (n=95)<span class=\"_ _25\"></span>Week 2 (n=92)",
	"kj8tvwa3Text": "SHAPS",
	"kj8tvwa4Text": "-1.0 (-1.7, -0.3),",
	"kj8tvwa5Text": "p=0.004",
	"kj8tvwa6Text": "Week 2 (n=92)",
	"kj8tvwa7Text": "MADRS",
	"kj8tvwa8Text": "-3.8 (-4.9, -2.7),",
	"kj8tvwa9Text": "p&lt;0.0001",
	"kj8tvwaaText": "Week 8 (n=79)",
	"kj8tvwabText": "SHAPS",
	"kj8tvwacText": "-2.9 (-3.7, -2.2),",
	"kj8tvwadText": "p&lt;0.0001",
	"kj8tvwaeText": "Week 8 (n=79)",
	"kj8tvwafText": "MADRS",
	"kj8tvwagText": "-7.1 (-8.2, -5.9),",
	"kj8tvwahText": "p&lt;0.0001",
	"kj8tvwaiText": "Zoom<span class=\"_ _26\"> </span>Zoom",
	"kj8tvwakText": "SHAPS/MADRS<span class=\"_\"> </span>EEfRT<span class=\"_ _2a\"></span><span class=\"ff1 fc3\">SHAPS/MADRS</span>",
	"Brintellix_34248035c1": "Text",
	"Brintellix_342dd502a9": "Text",
	"Brintellix_344d375d59": "Text",
	"Brintellix_345974d427": "Text",
	"Brintellix_34d8bf3742": "<span style=\"font-family: &quot;3_CCMVBT+AvenirNextLTPro-Demi&quot;; color: rgb(84, 122, 129); \">\n<font style=\"font-size: 25px;\">References</font>\n</span>",
	"Brintellix_348f1b6868": "<span style=\"font-family: &quot;2_PIDSIJ+AvenirNextLTPro-Regular&quot;; line-height: 1; color: rgb(100, 94, 94); display: block;\">\n<font style=\"font-size: 15px;\">\n\t<b>1.</b> Cao B et al. Front Psychiatry 2019;10:1–8.\n<br>\n</font>\n</span>",
	"Brintellix_340be77faf": "<span style=\"font-family: &quot;1_CWOXIJ+AvenirNextLTPro-Bold&quot;; color: rgb(84, 122, 129); line-height: 1;display:block;\">\n<font style=\"font-size: 22.5px;\">\n\tChange in SHAPS scores from baseline\n</font>\n</span>",
	"Brintellix_34dc2b9b4b": "<span style=\"font-family: &quot;1_CWOXIJ+AvenirNextLTPro-Bold&quot;; color: rgb(84, 122, 129); line-height: 1;display:block;\">\n<font style=\"font-size: 17.5px;\">\n\tSHAPS score\n</font>\n</span>",
	"Brintellix_348fa294b3": "<span style=\"font-family: &quot;3_CCMVBT+AvenirNextLTPro-Demi&quot;; line-height: 1; color: rgb(100, 94, 94); display: block;\">\n<font style=\"font-size: 16px;\">\n\tBaseline (n=95)\n</font>\n</span>",
	"Brintellix_34d0461630": "<span style=\"font-family: &quot;3_CCMVBT+AvenirNextLTPro-Demi&quot;; line-height: 1; color: rgb(100, 94, 94); display: block;text-align: center;\">\n<font style=\"font-size: 16px;\">\n\tWeek 2 (n=92)<br><font style=\"font-family: &quot;2_PIDSIJ+AvenirNextLTPro-Regular&quot;;\">ΔSHAPS<br>-1.0 (-1.7, -0.3),<br>p=0.004</font>\n</font>\n</span>",
	"Brintellix_34691df834": "<span style=\"font-family: &quot;3_CCMVBT+AvenirNextLTPro-Demi&quot;; line-height: 1; color: rgb(100, 94, 94); display: block;text-align: center;\">\n<font style=\"font-size: 16px;\">\n\tWeek 8 (n=79)<br><font style=\"font-family: &quot;2_PIDSIJ+AvenirNextLTPro-Regular&quot;;\">ΔSHAPS<br>-2.9 (-3.7, -2.2),<br>p&lt;0.0001</font>\n</font>\n</span>",
	"Brintellix_345eb4caf6": "<span style=\"font-family: &quot;1_CWOXIJ+AvenirNextLTPro-Bold&quot;; color: rgb(84, 122, 129); line-height: 1.2;display:block;\"><div style=\"text-align: center;\"><span style=\"font-size: 22.5px;\">Change in MADRS anhedonia</span></div>\n<font style=\"font-size: 22.5px;\"><div style=\"text-align: center;\">factor scores from baseline</div></font></span>",
	"Brintellix_346fdeacce": "<span style=\"font-family: &quot;1_CWOXIJ+AvenirNextLTPro-Bold&quot;; color: rgb(84, 122, 129); line-height: 1;display:block;\">\n<font style=\"font-size: 17.5px;\">\n\tMADRS anhedonia factor score\n</font>\n</span>",
	"Brintellix_34caadc76c": "<span style=\"font-family: &quot;3_CCMVBT+AvenirNextLTPro-Demi&quot;; line-height: 1; color: rgb(100, 94, 94); display: block;\">\n<font style=\"font-size: 16px;\">\n\tBaseline (n=95)\n</font>\n</span>",
	"Brintellix_3428bdbe9f": "<span style=\"font-family: &quot;3_CCMVBT+AvenirNextLTPro-Demi&quot;; line-height: 1.2; color: rgb(100, 94, 94); display: block;text-align: center;\">\n<font style=\"font-size: 16px;\">\n\tWeek 2 (n=92)<br><font style=\"font-family: &quot;2_PIDSIJ+AvenirNextLTPro-Regular&quot;;\">ΔMADRS<br>-3.8 (-4.9, -2.7),\n<br>p&lt;0.0001</font>\n</font>\n</span>",
	"Brintellix_345bf5ae8d": "<span style=\"font-family: &quot;3_CCMVBT+AvenirNextLTPro-Demi&quot;; line-height: 1.2; color: rgb(100, 94, 94); display: block;text-align: center;\">\n<font style=\"font-size: 16px;\">\n\tWeek 8 (n=79)<br><font style=\"font-family: &quot;2_PIDSIJ+AvenirNextLTPro-Regular&quot;;\">\nΔMADRS<br>-7.1 (-8.2, -5.9),<br>p&lt;0.0001</font>\n</font>\n</span>",
	"Brintellix_34e326a13e": "<div style=\"font-family: serif;font-family: '2_VDWFON+AvenirNextLTPro-Demi';font-size: 13px;background-color: #e5f0f2;box-sizing: border-box;color: #4d7f86;\">\n\t<div style=\"float: left;text-align: center;border-left: 1px solid #fff;padding: 4px 10px 2px;line-height:1.3;background-color: #e5f0f2;color: #fff;background: rgb(233,90,0);background: linear-gradient(90deg, rgba(233,90,0,1) 0%, rgba(240,125,0,1) 100%);background: -webkit-linear-gradient(90deg, rgba(233,90,0,1) 0%, rgba(240,125,0,1) 100%);\">SHAPS/MADRS</div>\n\t<div style=\"float: left;text-align: center;border-left: 1px solid #fff;padding: 4px 36.5px 2px;line-height:1.3;background-color: #e5f0f2;\">EEfRT</div>\n\t<div style=\"float: left;text-align: center;border-left: 1px solid #fff;padding: 4px 20px 2px;line-height:1.3;background-color: #e5f0f2;\">MADRS/SDS</div>\n</div>",
	"Brintellix_34564e32f5": "Text",
	"Brintellix_34aa57c523": "Text",
	"Brintellix_34621bbbd4": "Text",
	"Brintellix_34e53528ed": "Text",
	"Brintellix_3426542729": "Text",
	"Brintellix_3490e7160c": "<div style=\"font-family: serif;font-family: '2_VDWFON+AvenirNextLTPro-Demi';font-size: 13px;background-color: #e5f0f2;box-sizing: border-box;color: #4d7f86;\">\n\t<div style=\"float: left;text-align: center;border-left: 1px solid #fff;padding: 12px 37px;line-height:1.3;background-color: #e5f0f2;\">Asian</div>\n\t<div style=\"float: left;text-align: center;border-left: 1px solid #fff;padding: 12px 35px;line-height:1.3;background-color: #e5f0f2;\">Elderly</div>\n\t<div style=\"float: left;text-align: center;border-left: 1px solid #fff;padding: 12px 17px;line-height:1.3;background-color: #e5f0f2;\">Working population</div>\n\t<div style=\"float: left;text-align: center;border-left: 1px solid #fff;padding: 12px 22px;line-height:1.3;background-color: #e5f0f2;color: #fff;background: rgb(233,90,0);background: linear-gradient(90deg, rgba(233,90,0,1) 0%, rgba(240,125,0,1) 100%);background: -webkit-linear-gradient(90deg, rgba(233,90,0,1) 0%, rgba(240,125,0,1) 100%);\">Anhedonia</div>\n</div>",
	"Brintellix_340abf8799": "<div style=\"font-family: serif;font-family: '2_VDWFON+AvenirNextLTPro-Demi';font-size: 13px;background-color: #e5f0f2;box-sizing: border-box;color: #4d7f86;\">\n\t<div style=\"float: left;text-align: center;border-left: 1px solid #fff;padding: 13px 37px 11px;line-height:1.3;background-color: #e5f0f2;\">Asian</div>\n\t<div style=\"float: left;text-align: center;border-left: 1px solid #fff;padding: 13px 35px 11px;line-height:1.3;background-color: #e5f0f2;\">Elderly</div>\n\t<div style=\"float: left;text-align: center;border-left: 1px solid #fff;padding: 13px 17px 11px;line-height:1.3;background-color: #e5f0f2;\">Working population</div>\n\t<div style=\"float: left;text-align: center;border-left: 1px solid #fff;padding: 13px 22px 11px;line-height:1.3;background-color: #e5f0f2;color: #fff;background: rgb(233,90,0);background: linear-gradient(90deg, rgba(233,90,0,1) 0%, rgba(240,125,0,1) 100%);background: -webkit-linear-gradient(90deg, rgba(233,90,0,1) 0%, rgba(240,125,0,1) 100%);\">Anhedonia</div>\n</div>"
}
